NCT04365777

Brief Summary

Gliomas are the most common primary intracranial malignancy, and behavioral experiments in patients with supratentorial gliomas under sedation have shown potential neurological abnormalities; however, these behavioral experiments are susceptible to external influences. Therefore, more objective evidence is needed to support and extend the existing conclusions. The purpose of this study is to compare the EEG signatures (such as the EEG signal power) at various levels of anesthetics induced sedation in patients with supratentorial glioma in frontal lobe and in patients without intracranial-occupying lesion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 25, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 28, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

June 18, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 5, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 5, 2021

Completed
Last Updated

February 6, 2023

Status Verified

February 1, 2023

Enrollment Period

1.4 years

First QC Date

April 25, 2020

Last Update Submit

February 2, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • 1. The time-frequency characteristics of EEG power changes at different sedation depths in neurosurgical patients.

    The EEG power will be calculated by raw signal at awake, eye-closed state and after reaching the steady-state sedation depths of OAA/S=3 and OAA/S=1.

    Prior to anesthesia induction, three minutes after reaching the target level of sedation

Study Arms (3)

Awake State

OAA/S=5

Other: OAA/S=5

Sedation State

OAA/S=3

Other: OAA/S=3

Unconsciousness State

OAA/S=1

Other: OAA/S=1

Interventions

OAA/S=5OTHER

Prior to anesthesia induciton, EEG signatures will be recorded at Observer's Assessment of Alertness/Sedation (OAA/S) score of 5 (awake, eye-close state) for few minutes.

Awake State
OAA/S=3OTHER

Given sedative anesthetics (propofol, midazolam or dexmetomidine), EEG signatures will be recorded after reaching steady state of OAA/S=3 (responds only after name called loudly and/or repeatedly) for few minutes.

Sedation State
OAA/S=1OTHER

Increasing drug concentration, EEG signatures will be recorded after reaching steady state of OAA/S=1 (does not respond to noxious stimuli) for few minutes.

Unconsciousness State

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients aged between 18 and 60 years with American Society of Anesthesiology status I or II who were scheduled to receive elective surgery under general anesthesia. Patients with supratentorial glioma in right frontal lobe diagnosed by magnetic resonance imaging were included in the glioma group while patients requiring general anesthesia without intracranial-occupying lesion were included in the control group.

You may qualify if:

  • Patients with supratentorial glioma in right frontal lobe, and patients requiring general anesthesia without intracranial-occupying lesion;
  • Aged 18-60 years;
  • ASA I to II;
  • All those who sign the informed consent form.

You may not qualify if:

  • Obese patients, BMI\>30kg/m2;
  • Patients with Mallampati class III to IV airway anatomy;
  • Combined with other neurological or psychiatric diseases;
  • Combined with disturbance of consciousness;
  • Previous intracranial surgery;
  • Known or suspected cardiac dysfunction;
  • Allergic to intravenous general anesthetics;
  • Long-term history of analgesia, sedation and drug abuse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Beijing Tiantan Hospital

Beijing, Beijing Municipality, 100050, China

Location

Beijing TianTan Hospital

Beijing, 100070, China

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

April 25, 2020

First Posted

April 28, 2020

Study Start

June 18, 2020

Primary Completion

November 5, 2021

Study Completion

November 5, 2021

Last Updated

February 6, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations